ScholarIQanswers from OpenAlex & ORCID
E. William St. Clair
ResearcherPublications, citations & collaboration network
E. William St. Clair is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does E. William St. Clair have?
ScholarIQindexed works
E. William St. Clair has 260 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does E. William St. Clair have?
ScholarIQcitation count
E. William St. Clair has 33,596 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of E. William St. Clair?
ScholarIQh-index
E. William St. Clair has an h-index of 73 in OpenAlex.
What is the i10-index of E. William St. Clair?
ScholarIQi10-index
E. William St. Clair has an i10-index of 169 in OpenAlex.
What is the ORCID of E. William St. Clair?
ScholarIQorcid
The ORCID for E. William St. Clair is on the source record.
What is the OpenAlex record for E. William St. Clair?
ScholarIQopenalex
The OpenAlex for E. William St. Clair is on the source record.
What are the most-cited papers on E. William St. Clair?
ScholarIQmost cited works
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
Peter E. Lipsky, Désirée van der Heijde, E. William St. Clair, Daniel E. Fürst, Ferdinand C. Breedveld, Joachim R. Kalden, Josef S Smolen, Michael H. Weisman, Paul Emery, Marc Feldmann, Gregory R. Harriman, Ravinder N. Maini
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
Jasvinder A. Singh, Kenneth G. Saag, S. Louis Bridges, Elie A. Akl, Raveendhara R. Bannuru, Matthew C. Sullivan, Elizaveta E. Vaysbrot, Christine McNaughton, Mikala C. Osani, Robert H. Shmerling, Jeffrey R. Curtis, Daniel E. Furst, Deborah Parks, Arthur Kavanaugh, James R. O’Dell, Charles M. King, Amye Leong, Eric L. Matteson, John T. Schousboe, Barbara E. Drevlow, Seth Ginsberg, James Grober, E. William St. Clair, Elizabeth A. Tindall, Amy S. Miller, Timothy E. McAlindon
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
John H. Stone, Peter A. Merkel, Robert Spiera, Philip Seo, Carol A. Langford, Gary S. Hoffman, Cees G. M. Kallenberg, E. William St. Clair, Anthony Turkiewicz, Nadia K. Tchao, Lisa Webber, Linna Ding, Lourdes P. Sejismundo, Kathleen Mieras, David Weitzenkamp, David Iklé, Vicki Seyfert‐Margolis, Mark Mueller, Paul Brunetta, Nancy B. Allen, Fernando C. Fervenza, Duvuru Geetha, Karina A. Keogh, Eugene Y. Kissin, Paul A. Monach, Tobias Peikert, Coen A. Stegeman, Steven R. Ytterberg, Ulrich Specks
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
Ravinder N. Maini, E. William St. Clair, Ferdinand C. Breedveld, Daniel E. Fürst, Joachim R. Kalden, Michael H. Weisman, Josef S. Smolen, Paul Emery, Gregory R. Harriman, Marc Feldmann, Peter E. Lipsky
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
Jasvinder A. Singh, Kenneth G. Saag, S. Louis Bridges, Elie A. Akl, Raveendhara R. Bannuru, Matthew C. Sullivan, Elizaveta E. Vaysbrot, Christine McNaughton, Mikala C. Osani, Robert H. Shmerling, Jeffrey R. Curtis, Daniel E. Furst, Deborah Parks, Arthur Kavanaugh, James R. O’Dell, Charles M. King, Amye Leong, Eric L. Matteson, John T. Schousboe, Barbara E. Drevlow, Seth Ginsberg, James Grober, E. William St. Clair, Elizabeth A. Tindall, Amy S. Miller, Timothy E. McAlindon